Genomic software and services provider PierianDx plans to expand its unified sample-to-report software platform capabilities through the acquisition of genomics software company Tute Genomics.

"Danaher Corporation will acquire Phenomenex as part of a definitive agreement signed between the two."

Pursuant to the acquisition, PierianDx will be responsible for maintaining Tute Genomics solution until spring 2017, before the software platforms become fully integrated into CGW 6.0.

Danaher Corporation will acquire Phenomenex as part of a definitive agreement signed between the two.

Following the completion of the acquisition, Phenomenex will retain its brand and operate at the existing locations with its existing workforce.

The acquisition allows Danaher to improve its Danaher Business System (DBS) tools and Phenomenex to expand its research and development (R&D) capabilities.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now